Senate GOP eyes major reforms for health agencies

Senate Republicans are pledging to reform two of the government’s largest health agencies as part of their effort to fix a medical industry that they say “takes too long and costs too much” to find new cures.

In a wide-ranging report released Thursday, the GOP leaders of the Senate Health Committee announced plans to modernize both the National Institutes of Health (NIH) and the Food and Drug Administration (FDA), two agencies they said “every American is personally affected by.”


The two agencies have major roles in healthcare: The FDA is responsible for regulating all drugs and treatments, while the NIH is responsible for helping to create them.

But Sens. Lamar AlexanderLamar AlexanderThe Republicans' deep dive into nativism Senate GOP faces retirement brain drain The Hill's Morning Report - Presented by the National Shooting Sports Foundation - CDC news on gatherings a step toward normality MORE (R-Tenn.) and Richard BurrRichard Mauze BurrBattle lines drawn over Biden's support for vaccine waivers FDA unveils plan to ban menthol cigarettes, flavored cigars The Hill's Morning Report - Biden to country: 'Turning peril into possibility' MORE (R-N.C.) warn that “regulatory realities” of these agencies, particularly the FDA, often hinders private companies that are trying to create or sell their products.

They said the pace of the FDA is falling behind that of private companies and “in some cases, stifling innovation.”

“This both delays access to new therapies and treatments for U.S patients and drives expertise overseas,” they wrote. Instead, they are calling for greater private-public cooperation and smoother processes to approve companies’ new products.

At stake, the senators said, is the United States’ ability to compete in the field of medicine globally.

“For generations, America has led the world in medical innovation,” they wrote in the report. “But our global edge is slipping.”

The senators’ monthlong effort will complement one that has already been launched by the House Energy and Commerce Committee called 21st Century Cures.